1. Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis;High;J Am Acad Dermatol,2007
2. Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy;Swaminathan;Ann Intern Med,2006
3. Public health dispatch: fibrosing skin condition among patients with renal disease–United States and Europe, 1997-2002;Centers for Disease Control and Prevention;MMWR Morb Mortal Wkly Rep,2002
4. U.S. Renal Data System. USRDS 2006 annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2006.
5. A novel role for erythropoietin during fibrin-induced wound-healing response;Haroon;Am J Pathol,2003